A 68-year-old male with a history of heart failure with reduced ejection fraction and concurrent atrial fibrillation is being managed medically.
His physician adds a medication that works by inhibiting the Na+/K+-ATPase pump in myocardial cells.
This action leads to an increase in intracellular calcium.
Which of the following effects is the primary therapeutic goal of this medication in this patient?
